Aetiology and outcome of acute viral hepatitis in pregnancy

Journal of Gastroenterology and Hepatology
N C NayakK Buckshee

Abstract

The aetiologic types of sporadic acute viral hepatitis in 169 pregnant women were compared with those of 70 non-pregnant women and 287 adult men. The majority of pregnant women (87.6%) came with acute hepatitis in the last trimester of pregnancy. Non-A, non-B (NANB) hepatitis accounted for 81.6% of hepatitis during pregnancy in comparison with 48.6% in non-pregnant women and 57.1% in adult men. Hepatitis A was extremely uncommon during pregnancy. Hepatitis B infection accounted for 17% of all cases in pregnant women compared with 45% in controls. Acute viral hepatitis in pregnancy had a poor outcome as assessed by maternal and/or fetal mortality (28.5%). The outcome was equally bad in hepatitis NANB and hepatitis B. Pregnant women generally had significantly lower immunoglobulin levels in comparison with non-pregnant women. In acute NANB hepatitis during pregnancy, serum IgG and IgM levels were lower and higher, respectively, compared with those in non-pregnant women and pregnant women with acute hepatitis B. It is suggested that an immune suppression during pregnancy might be responsible for increased susceptibility to acute NANB viral hepatitis, which, by itself, seems to induce only a transient acute phase IgM response.

References

Oct 16, 1976·Lancet·A B ChristieM El-Nageh
May 19, 1979·Lancet·T J JohnA J Zuckerman
Oct 1, 1977·Postgraduate Medical Journal·Y E Cossart
Oct 1, 1977·The Journal of Pediatrics·J P HieberB Combes
Mar 12, 1988·Lancet·V Ramalingaswami, R H Purcell
Feb 1, 1986·Seminars in Liver Disease·J L Dienstag, H J Alter
Feb 1, 1987·Annals of Internal Medicine·K M De CockA G Redeker
Oct 1, 1987·The Journal of Infectious Diseases·I D Gust, R H Purcell
Sep 1, 1987·Journal of Medical Virology·V BalR S Kamat
Sep 1, 1983·American Journal of Epidemiology·M S KhurooM A Shah
Jan 1, 1984·Journal of Medical Virology·C GreenfieldH C Thomas
Feb 1, 1981·The American Journal of Medicine·M S KhurooM I Khuroo
Jun 1, 1982·Scandinavian Journal of Gastroenterology·B SmevikO Johansen

❮ Previous
Next ❯

Citations

Apr 21, 2004·The Journal of Biological Chemistry·Anindita Kar-RoyShahid Jameel
May 10, 2007·The Journal of Biological Chemistry·Syed Mohammad MoinShahid Jameel
Jun 9, 1990·BMJ : British Medical Journal·A J Zuckerman
Jul 6, 2014·BMC Infectious Diseases·Yong-Tao HanQiang Li
Mar 13, 2014·Journal of Medical Virology·Salam Gyaneshwori DeviShashi Sharma
Nov 26, 2010·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Ho Seong RyuJong Sun Rew
Dec 1, 1994·Leukemia & Lymphoma·M O MuenchM A Moore
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Simona Fiore, Valeria Savasi
Oct 31, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·N AlaviS D McDonald
Mar 13, 2008·European Journal of Gastroenterology & Hepatology·Coimbatore Azeez RasheedaVenkataraman Jayanthi
Aug 24, 2001·The Journal of Biological Chemistry·H KorkayaD Sahal
Feb 1, 2003·Journal of Viral Hepatitis·M S Khuroo, S Kamili
Jan 3, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Gyaneshwori Devi SalamShashi Sharma
Feb 13, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S P JaiswalD S Chitnis
Mar 28, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Thomas Horvatits, Sven Pischke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.